Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation

BackgroundObesity is complicated by low-grade chronic inflammation characterised by increases in inflammatory proteins and cells in peripheral blood. It has been known that omega-3 fatty acids (FA) like eicosapentaenoic (EPA) and docosahexaenoic (DHA) could modulate the inflammatory process and impr...

Full description

Bibliographic Details
Main Authors: Angélica Borja-Magno, Martha Guevara-Cruz, Adriana Flores-López, Silvia Carrillo-Domínguez, Julio Granados, Clorinda Arias, Mary Perry, Barry Sears, Hector Bourges, F. Enrique Gómez
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1156995/full
_version_ 1797833073638768640
author Angélica Borja-Magno
Martha Guevara-Cruz
Adriana Flores-López
Silvia Carrillo-Domínguez
Julio Granados
Clorinda Arias
Mary Perry
Barry Sears
Hector Bourges
F. Enrique Gómez
author_facet Angélica Borja-Magno
Martha Guevara-Cruz
Adriana Flores-López
Silvia Carrillo-Domínguez
Julio Granados
Clorinda Arias
Mary Perry
Barry Sears
Hector Bourges
F. Enrique Gómez
author_sort Angélica Borja-Magno
collection DOAJ
description BackgroundObesity is complicated by low-grade chronic inflammation characterised by increases in inflammatory proteins and cells in peripheral blood. It has been known that omega-3 fatty acids (FA) like eicosapentaenoic (EPA) and docosahexaenoic (DHA) could modulate the inflammatory process and improve metabolic markers.ObjectiveThis study aimed to determine the effect of high-dose omega-3 FA on metabolic and inflammatory markers among patients with obesity and healthy volunteers.MethodsThis prospective study included 12 women with obesity (body mass index [BMI] ≥ 35.0 kg/m2) and 12 healthy women (BMI < 24.0 kg/m2) who were supplemented with a dose of 4.8 g/day (3.2 g EPA plus 1.6 g DHA) for 3 months followed by no treatment for 1 month. Plasma metabolic and inflammatory markers and levels of mRNA transcripts of CD4+ T lymphocyte subsets were determined monthly.ResultsNone of the participants exhibited changes in weight or body composition after study completion. EPA and DHA supplementation improved metabolic (insulin, Homeostatic Model Assessment of Insulin Resistance [HOMA-IR], triglyceride [TG]/ high-density lipoprotein [HDL] ratio, TG, and arachidonic acid [AA]/EPA ratio) and tumor necrosis factor-alpha (TNF-α). Moreover, the levels of mRNA transcripts of T CD4+ lymphocyte subsets (TBX21, IFNG, GATA-3, interleukin [IL]-4, FOXP3, IL-10 IL-6, and TNF-α), were down-regulated during the intervention phase. After 1 month without supplementation, only insulin, HOMA-IR and the mRNA transcripts remained low, whereas all other markers returned to their levels before supplementation.ConclusionSupplementation with high-dose omega-3 FAs could modulate metabolism and inflammation in patients with obesity without weight loss or changes in body composition. However, these modulatory effects were ephemeral and with clear differential effects: short-duration on metabolism and long-lasting on inflammation.
first_indexed 2024-04-09T14:17:53Z
format Article
id doaj.art-dd8beaf151784483a7ebe21a3975ad0a
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-04-09T14:17:53Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-dd8beaf151784483a7ebe21a3975ad0a2023-05-05T06:03:17ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2023-05-011010.3389/fnut.2023.11569951156995Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementationAngélica Borja-Magno0Martha Guevara-Cruz1Adriana Flores-López2Silvia Carrillo-Domínguez3Julio Granados4Clorinda Arias5Mary Perry6Barry Sears7Hector Bourges8F. Enrique Gómez9Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoServicio de Nutriología Clínica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoDepartamento de Nutrición Animal, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoDepartamento de Trasplantes, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoDepartamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, MexicoInflammation Research Foundation, Peabody, MA, United StatesInflammation Research Foundation, Peabody, MA, United StatesDirección de Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoBackgroundObesity is complicated by low-grade chronic inflammation characterised by increases in inflammatory proteins and cells in peripheral blood. It has been known that omega-3 fatty acids (FA) like eicosapentaenoic (EPA) and docosahexaenoic (DHA) could modulate the inflammatory process and improve metabolic markers.ObjectiveThis study aimed to determine the effect of high-dose omega-3 FA on metabolic and inflammatory markers among patients with obesity and healthy volunteers.MethodsThis prospective study included 12 women with obesity (body mass index [BMI] ≥ 35.0 kg/m2) and 12 healthy women (BMI < 24.0 kg/m2) who were supplemented with a dose of 4.8 g/day (3.2 g EPA plus 1.6 g DHA) for 3 months followed by no treatment for 1 month. Plasma metabolic and inflammatory markers and levels of mRNA transcripts of CD4+ T lymphocyte subsets were determined monthly.ResultsNone of the participants exhibited changes in weight or body composition after study completion. EPA and DHA supplementation improved metabolic (insulin, Homeostatic Model Assessment of Insulin Resistance [HOMA-IR], triglyceride [TG]/ high-density lipoprotein [HDL] ratio, TG, and arachidonic acid [AA]/EPA ratio) and tumor necrosis factor-alpha (TNF-α). Moreover, the levels of mRNA transcripts of T CD4+ lymphocyte subsets (TBX21, IFNG, GATA-3, interleukin [IL]-4, FOXP3, IL-10 IL-6, and TNF-α), were down-regulated during the intervention phase. After 1 month without supplementation, only insulin, HOMA-IR and the mRNA transcripts remained low, whereas all other markers returned to their levels before supplementation.ConclusionSupplementation with high-dose omega-3 FAs could modulate metabolism and inflammation in patients with obesity without weight loss or changes in body composition. However, these modulatory effects were ephemeral and with clear differential effects: short-duration on metabolism and long-lasting on inflammation.https://www.frontiersin.org/articles/10.3389/fnut.2023.1156995/fullobesityinflammationmetabolismomega-3 fatty acidseicosapentaenoic (EPA)docosahexaenoic (DHA)
spellingShingle Angélica Borja-Magno
Martha Guevara-Cruz
Adriana Flores-López
Silvia Carrillo-Domínguez
Julio Granados
Clorinda Arias
Mary Perry
Barry Sears
Hector Bourges
F. Enrique Gómez
Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
Frontiers in Nutrition
obesity
inflammation
metabolism
omega-3 fatty acids
eicosapentaenoic (EPA)
docosahexaenoic (DHA)
title Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
title_full Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
title_fullStr Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
title_full_unstemmed Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
title_short Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
title_sort differential effects of high dose omega 3 fatty acids on metabolism and inflammation in patients with obesity eicosapentaenoic and docosahexaenoic acid supplementation
topic obesity
inflammation
metabolism
omega-3 fatty acids
eicosapentaenoic (EPA)
docosahexaenoic (DHA)
url https://www.frontiersin.org/articles/10.3389/fnut.2023.1156995/full
work_keys_str_mv AT angelicaborjamagno differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation
AT marthaguevaracruz differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation
AT adrianafloreslopez differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation
AT silviacarrillodominguez differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation
AT juliogranados differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation
AT clorindaarias differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation
AT maryperry differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation
AT barrysears differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation
AT hectorbourges differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation
AT fenriquegomez differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation